Thu, 27 Oct 2011 | DIVISION SALE
GlaxoSmithKline is planning to sell a swathe of consumer health product lines by the end of this year with a combined value of £700 million.
Advisers to the sale have been brought in and are said to be in discussion about the process. Brands for sale are those considered to be non-core by the group, and include the weight loss drug Alli.
The products generate £500 million per year in sales, and GSK aims to sell the lines for more than three times this amount.
The valuation figure of £700 million takes into account the costs of acquisition and the marketing funds spent to increase sales. Any additional amount above this that may be achieved in the sale would be treated as profits.
To satisfy investors’ demands for returns, GSK increased its planned level of share buy-backs for this year to £2.3 billion.
Separately it has been reported that GSK performed strongly in the third quarter. Group revenues were up by 3 per cent to £7.1 billion. The diabetes drug Avandia, herpes drug Valtrex and pandemic products had dragged on its sales, but this has lessened more recently.
Offered for sale is a highly regarded firm of commercial building consultants and surveyors, dedicated to providing expert advice and guidance in order to maximise the value of clients’ building assets.
The company designs, manufactures, installs, and maintains bespoke dust control equipment across the UK. Priding itself on its extensive in-house knowledge, the company provides a full range of filters, fans, and ducting, as well as offering annual C...
This business is a true powerhouse, offering customers everything they need to achieve their desired spaces in one convenient place. Whether they’re undertaking a full-scale renovation or searching for that perfect finishing touch, the solutions offe...
14
|
Jan
|
Intelligent Lending Group buys TotallyMoney | BUSINESS SALE
Fintech TotallyMoney has been bought by Manchester-based Int...
14
|
Jan
|
FDC exits Harry Needle Railroad Company after acquisition | BUSINESS SALE
Private equity firm Frontier Development Capital has exited ...
14
|
Jan
|
UK administrations update: January 7 – 14 | ADMINISTRATION
Since our last update, the following businesses have been co...
20
|
Jul
|
GSK puts Horlicks up for sale following review of UK business | DIVISION SALE
Drugs giant Glaxosmithkline will sell its Horlicks business ...
07
|
Sep
|
Japanese company in takeover talks with GSK over drinks brands | BUSINESS SALE
Suntory Beverage & Food is in discussion with GlaxoSmithKlin...
25
|
Apr
|
GSK puts Lucozade and Ribena on the market | DIVISION SALE
It has been confirmed that Lucozade and Ribena are on the ma...
Business Sale Report is your complete solution to finding great acquisition opportunities.
Join today to receive:
All this and much more, including the latest M&A news and exclusive resources
Please choose your settings for this site below. For more information please read our Cookie Policy
These cookies are necessary for our website to function properly and provide you with access to all features.
These are analytics cookies that help us to improve the way our website works.
These are used to improve the functional performance of the website and make it easier for you to use.